중증 하지 허혈 치료 시장 규모, 점유율 및 성장 분석 : 치료 유형별, 약제 유형별, 시술 유형별, 투여 경로별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Critical Limb Ischemia Treatment Market size was valued at USD 5.5 Billion in 2024 and is poised to grow from USD 5.9 Billion in 2025 to USD 10.28 Billion by 2033, growing at a CAGR of 7.2% during the forecast period (2026-2033).

The global critical limb ischemia (CLI) treatment market is essential in addressing the rising incidence of limb loss due to advanced peripheral artery disease, particularly driven by factors like diabetes and aging demographics. The market has transitioned from traditional open bypass surgeries to minimally invasive endovascular methods, including drug-coated balloons, innovative stents, and atherectomy systems, aiming to lower surgical risks and promote quicker recovery. Rapid advancements in endovascular technologies are key growth drivers, leading to reduced amputation rates and shorter hospital stays, thus incentivizing both payers and providers. Emerging markets present opportunities due to enhanced diagnostic capabilities and reimbursement improvements, paving the way for telemedicine and cost-effective treatment options that yield significant commercial benefits and improve patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Critical Limb Ischemia Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Critical Limb Ischemia Treatment Market Segments Analysis

Global critical limb ischemia treatment market is segmented by treatment type, drug type, procedure type, route of administration, end user and region. Based on treatment type, the market is segmented into Medications, Endovascular Procedures, Surgical Procedures, Cell & Gene Therapy and Others. Based on drug type, the market is segmented into Antiplatelet Drugs, Anticoagulants, Thrombolytic Agents, Vasodilators and Others. Based on procedure type, the market is segmented into Angioplasty, Stenting, Atherectomy, Bypass Surgery, Amputation and Others. Based on route of administration, the market is segmented into Oral, Injectable, Catheter-Based and Others. Based on end user, the market is segmented into Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Research Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Critical Limb Ischemia Treatment Market

The increasing incidence of diabetes, smoking-related illnesses, and an aging demographic has significantly expanded the number of individuals at risk for peripheral artery disease and critical limb ischemia. This surge in patients generates a heightened clinical demand for diagnostic evaluations, revascularization techniques, and limb preservation interventions. As a result, healthcare facilities and specialized clinics are prioritizing the procurement of devices tailored for critical limb ischemia and are increasingly adopting treatment protocols that emphasize minimally invasive approaches. This trend fosters a continuous market demand for products and services aimed at ensuring limb preservation, long-term vascular health, and comprehensive follow-up care.

Restraints in the Global Critical Limb Ischemia Treatment Market

The Global Critical Limb Ischemia Treatment market faces significant constraints due to the high expenses linked to advanced medical devices and consumables, as well as the intricate nature of associated procedures. This financial burden is exacerbated by inconsistent reimbursement policies and limitations imposed by payors, which restrict patient access and hinder healthcare providers from embracing newer, potentially beneficial therapies. Variability in coverage decisions and payment structures across different regions and institutions leads hospitals and clinicians to prefer established treatment protocols, thereby limiting the uptake of innovative, higher-cost options. Consequently, these challenges impede procurement priorities, slow down the adoption of advanced CLI solutions, and restrict overall market growth.

Market Trends of the Global Critical Limb Ischemia Treatment Market

The Global Critical Limb Ischemia Treatment market is witnessing a significant trend towards minimally invasive innovations, fueled by advancements in catheter technologies, drug-coated devices, and atherectomy systems. This shift prioritizes patient safety and procedural efficacy, making it possible to treat increasingly higher-risk individuals with reduced trauma. The industry's emphasis on device miniaturization, sophisticated delivery mechanisms, and targeted therapies is driving adoption among clinicians and fostering strategic partnerships with vascular specialists. Such innovations support outpatient procedures and accelerate patient recovery, while manufacturers are committed to generating robust clinical evidence and providing comprehensive training to ensure new devices seamlessly integrate into existing care pathways, ultimately expanding their global market presence.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis
• Case Studies
• Technology Assessment
• Customer & buying Criteria Analysis
• Pipeline Analysis
• Disease Epidemiology

Global Critical Limb Ischemia Treatment Market Size by Treatment Type & CAGR (2026-2033)

• Market Overview
• Medications
• Endovascular Procedures
• Surgical Procedures
• Cell & Gene Therapy
• Others

Global Critical Limb Ischemia Treatment Market Size by Drug Type & CAGR (2026-2033)

• Market Overview
• Antiplatelet Drugs
• Anticoagulants
• Thrombolytic Agents
• Vasodilators
• Others

Global Critical Limb Ischemia Treatment Market Size by Procedure Type & CAGR (2026-2033)

• Market Overview
• Angioplasty
• Stenting
• Atherectomy
• Bypass Surgery
• Amputation
• Others

Global Critical Limb Ischemia Treatment Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Injectable
• Catheter-Based
• Others

Global Critical Limb Ischemia Treatment Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Research Institutes
• Others

Global Critical Limb Ischemia Treatment Market Size & CAGR (2026-2033)

• North America (Treatment Type, Drug Type, Procedure Type, Route of Administration, End User)
  • US
  • Canada
• Europe (Treatment Type, Drug Type, Procedure Type, Route of Administration, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Treatment Type, Drug Type, Procedure Type, Route of Administration, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Treatment Type, Drug Type, Procedure Type, Route of Administration, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Treatment Type, Drug Type, Procedure Type, Route of Administration, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cordis Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shockwave Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integer Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spectranetics Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations